RxDoctor Payments Data

Sara Hargreaves, MD

Vascular Surgery · Lincoln, NENPI 1013141076

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $11,920 of the $17,228 with a category attached, or 69.2%. 30 manufacturers reported payments, led by Medtronic at 53.6% of the total. 2025 is the largest year on record at $11,581, 5.3 times the $2,169 reported in 2019.

$17,228in general payments, 2019–2025

Across 110 payments — averaging $156.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Penumbra, Inc.$3K
  • Inari Medical, Inc.$1K
  • W. L. Gore & Associates, Inc.$1K
  • Terumo Medical Corporation$932
  • Silk Road Medical, Inc.$510
  • plus $1K from 24 others

What the payments were for

  • Travel & lodging$11,92069%
  • Food & beverage$5,30831%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,228 in reported general payments places this provider in the 80th percentile of 35 vascular surgery providers in Nebraska.

See all vascular surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$138,544
Medicare patients
600
Services billed
1,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol44$956
ClopidogrelClopidogrel Bisulfate40$427
Atorvastatin Calcium14$91
Tramadol Hcl17$35

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →